Managing HIV disease without Delta

BMJ 1996; 312 doi: 10.1136/bmj.312.7045.1542b (Published 15 June 1996)
Cite this as: BMJ 1996;312:1542.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. R A Seaton,
  2. A J France,
  3. D Nathwani
  1. Career registrar Consultant physician Consultant physician Infection and Immunodeficiency Unit, Kings Cross Hospital, Dundee DD3 8EA

    EDITOR,—The editorial by Anthony J Pinching gives further news of the two large randomised placebo controlled trials of combination antiretroviral therapy in advanced HIV infection. Although the apparent beneficial results have been widely publicised, neither Delta nor ACTG175 have yet been …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL